442 related articles for article (PubMed ID: 19913918)
21. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
22. Chlorido-, aqua-, 9-ethylguanine- and 9-ethyladenine-adducts of cytotoxic ruthenium arene complexes containing O,O-chelating ligands.
Melchart M; Habtemariam A; Parsons S; Sadler PJ
J Inorg Biochem; 2007 Nov; 101(11-12):1903-12. PubMed ID: 17582501
[TBL] [Abstract][Full Text] [Related]
23. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.
Ekengard E; Glans L; Cassells I; Fogeron T; Govender P; Stringer T; Chellan P; Lisensky GC; Hersh WH; Doverbratt I; Lidin S; de Kock C; Smith PJ; Smith GS; Nordlander E
Dalton Trans; 2015 Nov; 44(44):19314-29. PubMed ID: 26491831
[TBL] [Abstract][Full Text] [Related]
24. Bifunctional amine-tethered ruthenium(II) arene complexes form monofunctional adducts on DNA.
Melchart M; Habtemariam A; Novakova O; Moggach SA; Fabbiani FP; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2007 Oct; 46(21):8950-62. PubMed ID: 17850143
[TBL] [Abstract][Full Text] [Related]
25. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
[TBL] [Abstract][Full Text] [Related]
26. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
27. Syntheses and DNA-binding studies of two ruthenium(II) complexes containing one ancillary ligand of bpy or phen: [Ru(bpy)(pp[2,3]p)2](ClO4)2 and [Ru(phen)(pp[2,3]p)2](ClO4)2.
Wu BY; Gao LH; Duan ZM; Wang KZ
J Inorg Biochem; 2005 Aug; 99(8):1685-91. PubMed ID: 16005071
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
Tan C; Liu J; Chen L; Shi S; Ji L
J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
[TBL] [Abstract][Full Text] [Related]
29. One-pot synthesis of symmetric and asymmetric p-quinone ligands and unprecedented substituent induced reactivity in their dinuclear ruthenium complexes.
Schweinfurth D; Das HS; Weisser F; Bubrin D; Sarkar B
Inorg Chem; 2011 Feb; 50(3):1150-9. PubMed ID: 21214266
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
31. Complexation of the triply-bonded dirhenium(II) complex Re(2)Cl(4)(mu-dppm)(2) (dppm = Ph(2)PCH(2)PPh(2)) by up to three acetylene molecules.
Ganesan M; Shih KY; Fanwick PE; Walton RA
Inorg Chem; 2003 Feb; 42(4):1241-7. PubMed ID: 12588162
[TBL] [Abstract][Full Text] [Related]
32. Enhanced DNA photocleavage properties of Ru(II) terpyridine complexes upon incorporation of methylphenyl substituted terpyridine and/or the polyazine bridging ligand dpp (2,3-bis(2-pyridyl)pyrazine).
Jain A; Slebodnick C; Winkel BS; Brewer KJ
J Inorg Biochem; 2008 Oct; 102(10):1854-61. PubMed ID: 18674819
[TBL] [Abstract][Full Text] [Related]
33. Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells.
Martínez A; Rajapakse CS; Sánchez-Delgado RA; Varela-Ramirez A; Lema C; Aguilera RJ
J Inorg Biochem; 2010 Sep; 104(9):967-77. PubMed ID: 20605217
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization and DNA-binding studies of ruthenium(II) mixed-ligand complexes containing dipyrido[1,2,5]oxadiazolo[3,4-b]quinoxaline.
Peng B; Chen X; Du KJ; Yu BL; Chao H; Ji LN
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Nov; 74(4):896-901. PubMed ID: 19748821
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, structure, DNA-binding properties, and cytotoxicity of ruthenium(II) polypyridyl complexes.
Liu YJ; Zeng CH; Yao JH; Wu FH; He LX; Huang HL
Chem Biodivers; 2010 Jul; 7(7):1770-83. PubMed ID: 20658665
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity, apoptosis, cellular uptake, cell cycle arrest, photocleavage, and antioxidant activity of 1, 10-phenanthroline ruthenium(II) complexes.
Liu YJ; Li ZZ; Liang ZH; Yao JH; Huang HL
DNA Cell Biol; 2011 Oct; 30(10):839-48. PubMed ID: 21568758
[TBL] [Abstract][Full Text] [Related]
37. Ruthenium(II) polypyridyl complexes: potential precursors, metalloligands, and topo II inhibitors.
Sharma S; Singh SK; Pandey DS
Inorg Chem; 2008 Feb; 47(3):1179-89. PubMed ID: 18171055
[TBL] [Abstract][Full Text] [Related]
38. Tuning the hydrophobicity of ruthenium(II)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy.
Scolaro C; Chaplin AB; Hartinger CG; Bergamo A; Cocchietto M; Keppler BK; Sava G; Dyson PJ
Dalton Trans; 2007 Nov; (43):5065-72. PubMed ID: 17992291
[TBL] [Abstract][Full Text] [Related]
39. DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
Moreno V; Font-Bardia M; Calvet T; Lorenzo J; Avilés FX; Garcia MH; Morais TS; Valente A; Robalo MP
J Inorg Biochem; 2011 Feb; 105(2):241-9. PubMed ID: 21194624
[TBL] [Abstract][Full Text] [Related]
40. Organometallic complexes for nonlinear optics. 43. Quadratic optical nonlinearities of dipolar alkynylruthenium complexes with phenyleneethynylene/phenylenevinylene bridges.
Rigamonti L; Babgi B; Cifuentes MP; Roberts RL; Petrie S; Stranger R; Righetto S; Teshome A; Asselberghs I; Clays K; Humphrey MG
Inorg Chem; 2009 Apr; 48(8):3562-72. PubMed ID: 19298046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
